MADD is a downstream target of PTEN in triggering apoptosis
Shankar Jayarama1, Liang-Cheng Li, Lakshmy Ganesh
1Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, 60612.
Abstract:
Mitogen-activated kinase activating death domain containing protein (MADD) is abundantly expressed in cancer cells and necessary for maintaining cancer cell survival. However, this survival function of MADD is dependent upon its phosphorylation by protein kinase B (Akt). The tumour suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a lipid phosphatase that negatively regulates the phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway. The downstream targets of PTEN in triggering apoptosis have not yet been completely identified. Here, we report that MADD can act as a pro-apoptotic factor to initiate TRAIL-induced apoptosis when its phosphorylation is attenuated by PTEN. Our data show that tumor necrosis factor α-related apoptosis-inducing ligand (TRAIL) induced a reduction in MADD phosphorylation with a concomitant up-regulation of PTEN. Knock down of PTEN using a specific siRNA prevented TRAIL-induced reduction in pMADD levels. Surprisingly, Akt non-phosphorylated MADD translocated from the plasma membrane to cytoplasm where it bound to 14-3-3 and displaced 14-3-3 associated Bax, which translocated to mitochondria resulting in cytochrome c release. Taken together, our data reveal that PTEN can convey the death signal by preventing MADD phosphorylation by Akt.
Insights
PTEN suppresses cancer cell survival by reducing MADD phosphorylation, which initiates apoptosis. This reveals a new PTEN mechanism in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Mitogen-activated kinase activating death domain containing protein (MADD) promotes cancer cell survival via Akt phosphorylation.
- PTEN (phosphatase and tensin homolog deleted on chromosome 10) negatively regulates the PI3K-Akt pathway, but its downstream apoptosis targets are unclear.
Purpose of the Study:
- To investigate the role of PTEN in regulating MADD phosphorylation and its impact on apoptosis.
- To elucidate the mechanism by which PTEN influences MADD's pro-apoptotic function in TRAIL-induced apoptosis.
Main Methods:
- Utilized siRNA to knock down PTEN expression.
- Analyzed MADD phosphorylation levels following TRAIL treatment.
- Investigated MADD subcellular localization and its interaction with 14-3-3 and Bax using western blotting and microscopy.
Main Results:
- TRAIL treatment reduced MADD phosphorylation and increased PTEN levels; PTEN knockdown blocked this reduction.
- PTEN-mediated dephosphorylation caused MADD to translocate from the plasma membrane to the cytoplasm.
- Cytoplasmic MADD displaced Bax from 14-3-3, leading to Bax mitochondrial translocation and cytochrome c release.
Conclusions:
- PTEN acts as a crucial mediator of TRAIL-induced apoptosis by inhibiting Akt-mediated MADD phosphorylation.
- This study identifies a novel PTEN-MADD axis in apoptosis signaling, revealing MADD as a key downstream target.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Abnormal Proliferation
Caspases


